Healthcare provider profile · identity verified

Alejandro Rios, MD

Family Practice · SAN DIEGO, CA · NPI 1225187628

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	568	224
Amlodipine Besylate	Amlodipine Besylate	294	115
Lisinopril	Lisinopril	290	105
Losartan Potassium	Losartan Potassium	271	93
Metformin Hcl Er	Metformin Hcl	242	87
Rosuvastatin Calcium	Rosuvastatin Calcium	200	87
Metformin Hcl	Metformin Hcl	176	63
Omeprazole	Omeprazole	158	68
Glipizide	Glipizide	127	48
Metoprolol Tartrate	Metoprolol Tartrate	127	52
Gabapentin	Gabapentin	126	60
Levothyroxine Sodium	Levothyroxine Sodium	112	45
Jardiance	Empagliflozin	107	43
Albuterol Sulfate Hfa	Albuterol Sulfate	91	41
Alendronate Sodium	Alendronate Sodium	91	37
Hydrochlorothiazide	Hydrochlorothiazide	89	31
Simvastatin	Simvastatin	87	30
Tamsulosin Hcl	Tamsulosin Hcl	86	42
Furosemide	Furosemide	84	29
Potassium Chloride	Potassium Chloride	84	26
Trazodone Hcl	Trazodone Hcl	81	31
Terazosin Hcl	Terazosin Hcl	80	35
Atenolol	Atenolol	79	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	78	25
Glipizide Er	Glipizide	70	27
Meloxicam	Meloxicam	68	46
Pantoprazole Sodium	Pantoprazole Sodium	65	21
Ibuprofen	Ibuprofen	61	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	23
Humulin N	Insulin Nph Human Isophane	54	19
Pradaxa	Dabigatran Etexilate Mesylate	54	16
Fluticasone Propionate	Fluticasone Propionate	53	23
Famotidine	Famotidine	52	24
Finasteride	Finasteride	50	20
Allopurinol	Allopurinol	39	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	38	15
Eliquis	Apixaban	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	21
Fluoxetine Hcl	Fluoxetine Hcl	33	12
Metoprolol Succinate	Metoprolol Succinate	33	suppressed
Ozempic	Semaglutide	32	11
Clopidogrel	Clopidogrel Bisulfate	31	13
Sertraline Hcl	Sertraline Hcl	31	19
Pioglitazone Hcl	Pioglitazone Hcl	30	12
Propranolol Hcl	Propranolol Hcl	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	17
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	26	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	15
Cephalexin	Cephalexin	25	25
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Hydrocortisone	Hydrocortisone	25	11
Alvesco	Ciclesonide	24	13
Victoza 2-Pak	Liraglutide	24	11
Wixela Inhub	Fluticasone Propion/Salmeterol	24	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	22	22
Doxycycline Monohydrate	Doxycycline Monohydrate	22	19
Humulin R	Insulin Regular, Human	22	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Naloxone Hcl	Naloxone Hcl	12	11
Nifedipine Er	Nifedipine	12	suppressed
Prednisone	Prednisone	12	12
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error